Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Vidal

Research group


Abstract

Our past and current objectives encompass the design and development of efficient catalytic enantioselective methodologies and their application to the preparation of targets of biological, pharmacological and agrochemical relevance. Designing modular catalysts and versatile synthetic procedures for their preparation, and performing computational analyses of the catalytic event, are key elements in our strategy.

Two main objectives are pursued within the group: In the first instance, we aim to develop, using versatile covalent chemistry, highly modular enantiopure POP ligands for asymmetric organometallic catalytic synthesis. Secondly, we aim to devise strategies to generate a set of supramolecular chiral ligands which resemble a privileged structure yet at the same time offer a range of closely related geometrically active sites.

Topics addressed

  • Supported catalysts and flow processes
  • Development of smart catalytic systems
  • Superparamagnetic nanoparticles

Articles

“Rhodium-Catalysed Asymmetric Hydrogenation as a Valuable Synthetic Tool for the Preparation of Chiral Drugs”
Chem. Soc. Rev. (2013) 728-754
P. Etayo, A. Vidal-Ferran

“[Ir(P-OP)]-Catalyzed Asymmetric Hydrogenation of Diversely Substituted C=N- Containing Heterocycles”
Org. Lett. (2013) 2066-2069
J. L. Núñez-Rico, A. Vidal-Ferran

“Bis(phosphite) Ligands with Distal Regulation: Applications in Rhodium-mediated Asymmetric Hydroformylations”
Chem. Eur. J. 2013 2720-272
I. Mon, D. Amilan Jose, A. Vidal-Ferran

“Small Bite-Angle P-OP Ligands for Asymmetric Hydroformylation and Hydrogenation”
Org. Lett.2013 3634-3637
H. Fernández-Pérez, J. Benet-Buchholz, A. Vidal-Ferran

“Catalytic Enantioselective Reductive Desymmetrisation of Achiral and Meso Compounds”
Chem. Commun. 2013 10666-10675
H. Fernández-Pérez, P. Etayo, J. R. Lao, J. L. Núñez-Rico, A. Vidal-Ferran